To access this element change to forms mode OFF
Grant Award View - GA65791
Effectiveness of novel approaches to radical cure of vivax malaria
GA ID:
GA65791
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$1,599,228.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Clinical Trials and Cohort Studies
Grant Activity:
Effectiveness of novel approaches to radical cure of vivax malaria
Purpose:
Vivax malaria is characterised by its tendency to recur weeks or months after the initial infection. These relapses are caused by dormant liver forms. The only available drug to treat them is primaquine, which can cause damage to red blood cells in some patients, so the drug is given at a low dose over a longer period of time resulting in low adherence. This trial explores other treatment options and will provide country programs evidence of their effectiveness.
GO ID:
GO Title:
Clinical Trials and Cohort Studies 2019 Grant Opportunity
Internal Reference ID:
GNT1182950
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Menzies School of Health Research
Recipient ABN:
70 413 542 847
Grant Recipient Location
Suburb:
Casuarina
Town/City:
Casuarina
Postcode:
0810
State/Territory:
NT
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, NT, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, ETHIOPIA, INDONESIA, THAILAND